Unknown

Dataset Information

0

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

ABSTRACT:

SUBMITTER: Costa-Cabral S 

PROVIDER: S-EPMC4835098 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
| S-EPMC4755568 | biostudies-literature
Unknown Synthetic Lethal Vulnerabilities in <i>KRAS</i>-Mutant Cancers.
| S-EPMC5990478 | biostudies-literature
Unknown A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS.
| S-EPMC7319959 | biostudies-literature
Unknown Defeat mutant KRAS with synthetic lethality.
| S-EPMC5680709 | biostudies-literature
Unknown Synthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA delivery.
| S-EPMC4015238 | biostudies-literature
Unknown Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models.
| S-EPMC3667614 | biostudies-literature
Transcriptomics SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
2024-04-15 | GSE240874 | GEO
Unknown ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.
| S-EPMC5159945 | biostudies-literature
Unknown Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors.
| S-EPMC3378149 | biostudies-literature
Unknown Mutant KRAS is a druggable target for pancreatic cancer.
| S-EPMC3870687 | biostudies-literature